Free Trial

Bluejay Diagnostics (BJDX) Competitors

Bluejay Diagnostics logo
$1.46 -0.06 (-3.95%)
Closing price 04:00 PM Eastern
Extended Trading
$1.44 -0.01 (-1.03%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BJDX vs. LFWD, HSCS, SSKN, PTHL, AMIX, HSDT, LUCY, QNRX, NUWE, and GCTK

Should you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include Lifeward (LFWD), HeartSciences (HSCS), Strata Skin Sciences (SSKN), Pheton (PTHL), Autonomix Medical (AMIX), Helius Medical Technologies (HSDT), Innovative Eyewear (LUCY), Quoin Pharmaceuticals (QNRX), Nuwellis (NUWE), and GlucoTrack (GCTK). These companies are all part of the "medical equipment" industry.

Bluejay Diagnostics vs. Its Competitors

Bluejay Diagnostics (NASDAQ:BJDX) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

Bluejay Diagnostics has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500. Comparatively, Lifeward has a beta of 0.16, indicating that its share price is 84% less volatile than the S&P 500.

In the previous week, Bluejay Diagnostics' average media sentiment score of 0.00 equaled Lifeward'saverage media sentiment score.

Company Overall Sentiment
Bluejay Diagnostics Neutral
Lifeward Neutral

18.5% of Bluejay Diagnostics shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 0.1% of Bluejay Diagnostics shares are held by insiders. Comparatively, 2.7% of Lifeward shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Lifeward has a consensus price target of $9.00, indicating a potential upside of 1,498.86%. Given Lifeward's stronger consensus rating and higher probable upside, analysts plainly believe Lifeward is more favorable than Bluejay Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bluejay Diagnostics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Lifeward
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Bluejay Diagnostics has higher earnings, but lower revenue than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bluejay Diagnostics$250K8.70-$7.72M-$125.15-0.01
Lifeward$25.66M0.34-$28.94M-$3.12-0.18

Bluejay Diagnostics has a net margin of 0.00% compared to Lifeward's net margin of -121.80%. Lifeward's return on equity of -137.91% beat Bluejay Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Bluejay DiagnosticsN/A -362.07% -299.10%
Lifeward -121.80%-137.91%-90.28%

Summary

Lifeward beats Bluejay Diagnostics on 9 of the 14 factors compared between the two stocks.

Get Bluejay Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BJDX vs. The Competition

MetricBluejay DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$2.27M$6.82B$5.79B$10.40B
Dividend YieldN/A1.20%5.63%4.60%
P/E Ratio-0.0126.7876.4826.75
Price / Sales8.70197.91531.95124.23
Price / CashN/A22.0337.9261.55
Price / Book0.144.9813.726.40
Net Income-$7.72M$178.07M$3.29B$271.62M
7 Day Performance-7.01%5.36%1.03%2.85%
1 Month Performance12.31%9.65%6.32%9.64%
1 Year Performance-80.84%18.22%81.16%31.62%

Bluejay Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BJDX
Bluejay Diagnostics
N/A$1.46
-3.9%
N/A-79.6%$2.27M$250K-0.019
LFWD
Lifeward
2.2349 of 5 stars
$0.54
+1.5%
$9.00
+1,572.2%
-82.4%$8.32M$25.66M-0.1760
HSCS
HeartSciences
2.2902 of 5 stars
$3.33
flat
$13.00
+290.4%
+25.3%$7.58MN/A-0.3610
SSKN
Strata Skin Sciences
2.1087 of 5 stars
$1.74
-2.2%
$6.00
+244.8%
-48.2%$7.42M$33.56M-0.61120Gap Down
PTHL
Pheton
N/A$0.91
-10.8%
N/A-78.9%$6.71M$450K0.0011News Coverage
Gap Down
AMIX
Autonomix Medical
1.8101 of 5 stars
$1.17
+4.9%
$5.00
+327.4%
-92.4%$6.60MN/A-0.201Gap Up
HSDT
Helius Medical Technologies
1.2924 of 5 stars
$5.88
-1.0%
N/A-96.2%$6.40M$520K0.0030News Coverage
Gap Up
LUCY
Innovative Eyewear
0.4342 of 5 stars
$1.77
-7.3%
N/A-76.5%$6.30M$1.64M-0.649Short Interest ↓
QNRX
Quoin Pharmaceuticals
1.1255 of 5 stars
$7.67
+0.6%
N/A-60.5%$4.45MN/A-0.184Gap Up
NUWE
Nuwellis
1.0611 of 5 stars
$4.77
-2.3%
N/A-92.9%$4.41M$8.74M-0.1370Gap Down
GCTK
GlucoTrack
0.409 of 5 stars
$4.74
-3.1%
N/A-99.8%$4.40MN/A-0.085Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:BJDX) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners